Phibro Animal Health Corporation and Epitopix, LLC form Poultry Vaccine Partnership
Teaneck, NJ and Willmar, MN – November 19, 2013 Phibro Animal Health Corporation and Epitopix have entered into a partnership to manufacture and market biological products for chickens in the United States based on Epitopix’s novel SRP® technology. Additionally, the parties intend to collaborate on a global basis to develop unique poultry biological products based on this technology. “We are very excited about combining the novel technology and experience of Epitopix with Phibro’s global expertise in developing innovative poultry vaccines, supported in the field by Phibro’s sales and technical service team. Our two companies share very similar values and cultures, which makes this partnership an ideal fit,” said Larry Miller, President, Phibro Animal Health.
“We are delighted to have this opportunity to commercialize our SRP technology in the poultry market. This partnership will help poultry producers access a superior immunological solution for control of salmonella, E. coli and other gram-negative pathogens,” said Jim Sandstrom, DVM, General Manager, Epitopix, LLC.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and nutrition products to the poultry, swine, cattle and aquaculture markets.
Epitopix discovers, develops, and manufactures USDA licensed veterinary vaccines based on a patented technology platform called SRP® (siderophore receptor proteins). Epitopix vaccines improve animal health, with a focus on reducing pathogenic bacteria in food animals. Epitopix is an affiliate of Life-Science Innovations, which through its affiliate Ag Forte, LLC is the largest producer of hatched turkeys in North America.